BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38138504)

  • 1. Engineering a New IFN-ApoA-I Fusion Protein with Low Toxicity and Prolonged Action.
    Miroshnichenko S; Pykhtina M; Kotliarova A; Chepurnov A; Beklemishev A
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression in Pichia pastoris and properties of human serum albumin-interferon alpha2b chimera].
    Chang SH; Gong X; Yang ZY; Wang TY; Ma GC; Ma QJ; Wu J
    Sheng Wu Gong Cheng Xue Bao; 2006 Mar; 22(2):173-9. PubMed ID: 16607939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.
    Schuhenn J; Meister TL; Todt D; Bracht T; Schork K; Billaud JN; Elsner C; Heinen N; Karakoese Z; Haid S; Kumar S; Brunotte L; Eisenacher M; Di Y; Lew J; Falzarano D; Chen J; Yuan Z; Pietschmann T; Wiegmann B; Uebner H; Taube C; Le-Trilling VTK; Trilling M; Krawczyk A; Ludwig S; Sitek B; Steinmann E; Dittmer U; Lavender KJ; Sutter K; Pfaender S
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35131898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of potent long-lasting consensus interferon using albumin fusion technology in Pichia pastoris expression system.
    Naseem MU; Ahmed N; Khan MA; Tahir S; Zafar AU
    Protein Expr Purif; 2020 Feb; 166():105509. PubMed ID: 31604114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of latent Interferon alpha 2b as a safe therapeutic for treatment of Hepatitis C virus infection.
    Gull I; Aslam MS; Tipu I; Mushtaq R; Ali TZ; Athar MA
    Sci Rep; 2019 Jul; 9(1):10867. PubMed ID: 31350425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and characterization of a potent, long-lasting recombinant human serum albumin-interferon α1 fusion protein expressed in Pichia pastoris.
    Tian S; Li Q; Yao W; Xu C
    Protein Expr Purif; 2013 Aug; 90(2):124-8. PubMed ID: 23748141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction, expression and characterization of human interferon alpha2b-(G4S)n-thymosin alpha1 fusion proteins in Pichia pastoris.
    Yang YF; Yuan HY; Liu NS; Chen XL; Gao BY; Lu H; Li YY
    World J Gastroenterol; 2005 May; 11(17):2597-602. PubMed ID: 15849818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular expression and antiviral activity of a bovine interferon-alpha through codon optimization in Pichia pastoris.
    Tu Y; Wang G; Wang Y; Chen W; Zhang L; Liu Y; Jiang C; Wang S; Bu Z; Cai X
    Microbiol Res; 2016 Oct; 191():12-8. PubMed ID: 27524649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro inhibition of SARS virus replication by human interferons.
    Dahl H; Linde A; Strannegård O
    Scand J Infect Dis; 2004; 36(11-12):829-31. PubMed ID: 15764169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [
    Loginova SY; Shсhukina VN; Savenko SV; Borisevich SV
    Vopr Virusol; 2021 May; 66(2):123-128. PubMed ID: 33993682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fusion protein of IFN-α and apolipoprotein A-I crosses the blood-brain barrier by a saturable transport mechanism.
    Fioravanti J; Medina-Echeverz J; Ardaiz N; Gomar C; Parra-Guillén ZP; Prieto J; Berraondo P
    J Immunol; 2012 Apr; 188(8):3988-92. PubMed ID: 22422884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of a potent, long-lasting recombinant human serum albumin-interferon-alpha2b fusion protein expressed in Pichia pastoris.
    Huang YS; Chen Z; Yang ZY; Wang TY; Zhou L; Wu JB; Zhou LF
    Eur J Pharm Biopharm; 2007 Sep; 67(2):301-8. PubMed ID: 17418549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of N-glycosylation by site mutation further prolongs the half-life of IFN-α/Fc fusion proteins expressed in Pichia pastoris.
    Jia H; Guo Y; Song X; Shao C; Wu J; Ma J; Shi M; Miao Y; Li R; Wang D; Tian Z; Xiao W
    Microb Cell Fact; 2016 Dec; 15(1):209. PubMed ID: 27927205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfer of C-terminal residues of human apolipoprotein A-I to insect apolipophorin III creates a two-domain chimeric protein with enhanced lipid binding activity.
    Horn JVC; Ellena RA; Tran JJ; Beck WHJ; Narayanaswami V; Weers PMM
    Biochim Biophys Acta Biomembr; 2017 Aug; 1859(8):1317-1325. PubMed ID: 28434970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anchoring interferon alpha to apolipoprotein A-I reduces hematological toxicity while enhancing immunostimulatory properties.
    Fioravanti J; González I; Medina-Echeverz J; Larrea E; Ardaiz N; González-Aseguinolaza G; Prieto J; Berraondo P
    Hepatology; 2011 Jun; 53(6):1864-73. PubMed ID: 21425312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Half-life extension of porcine interferon-α by fusion to the IgG-binding domain of streptococcal G protein.
    Zong Y; Tan X; Xiao J; Zhang X; Xia X; Sun H
    Protein Expr Purif; 2019 Jan; 153():53-58. PubMed ID: 30165247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Purification of the chimeric protein Alburon16 from a culture medium of the yeast Pichia pastoris].
    Karabel'skiĭ AV; Padkina MV
    Prikl Biokhim Mikrobiol; 2012; 48(4):457-62. PubMed ID: 23035580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and biological activity of long-acting recombinant human interferon-α2b.
    Zhang Q; Wang C; Ma F; Yao L; Gao H; Zhu L; Zheng L
    BMC Biotechnol; 2020 Mar; 20(1):16. PubMed ID: 32169063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intact bioactivities and improved pharmacokinetic of the SL335-IFN-β-1a fusion protein that created by genetic fusion of SL335, a human anti-serum albumin fab, and human interferon-β.
    Ji SI; Park JH; You HG; Chi HJ; Bang YW; Cha SH
    Immunol Lett; 2019 Mar; 207():46-55. PubMed ID: 30684504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus.
    Subramanian GM; Moore PA; Gowen BB; Olsen AL; Barnard DL; Paragas J; Hogan RJ; Sidwell RW
    Chemotherapy; 2008; 54(3):176-80. PubMed ID: 18560223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.